{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-000341","form_type":"8-K","ticker":"ANGO","cik":"0001275187","company_name":"ANGIODYNAMICS INC","filed_at":"2026-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.690457+00:00","generated_at":"2026-05-16T11:29:52.399346+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"AngioDynamics Q2 beats; raises FY26 guidance; CEO Clemmer to retire; Med Tech growth +13%","bullets":["Q2 net sales $79.4M (+8.8% YoY); Med Tech $35.7M (+13.0%); GAAP EPS -$0.15, adj. EPS $0.00.","Raised FY26 net sales guidance to $312-314M (from $308-313M); Adj. EBITDA raised to $8-10M (from $6-10M).","CEO Jim Clemmer to retire in FY2027; board initiates search; Q2 generated $4.7M cash, debt-free balance sheet.","FDA IDE approvals for APEX-Return (AlphaVac blood management) and PAVE (AngioVac right-sided endocarditis) studies.","Federal Circuit affirmed Bard patent invalidation, eliminating $3M contingent payment obligation from prior settlement."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-000341","json":"https://secwatch.observer/filing/0001140361-26-000341.json","markdown":"https://secwatch.observer/filing/0001140361-26-000341.md","text":"https://secwatch.observer/filing/0001140361-26-000341.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126000341/0001140361-26-000341-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126000341/ef20062354_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:29:52.399346+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}